ClinicalTrials.gg
RecruitingNCT05289999REAVIRUpdated Jul 1, 2026

Interest of the Virtual Reality as an Analgesic Support and in the Management the Pre-procedural Anxiety in Rheumatology

An interventional study of Virtual reality headset for first injection and Virtual reality headset for second injection in Radiculopathy, sponsored by Centre Hospitalier le Mans. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by Centre Hospitalier le Mans · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Jun 2022; still recruiting 4 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

As a part of the current rheumatological practice skills, epidural injections through the sacrococcygeal hiatus take part in the strategy for managing radicular diseases. This technical act is easily performed in an outpatient context since it is a brief procedure, performed under clinical and ultrasound control, with good tolerance. Nevertheless, epidural injections by the way of the sacrococcygeal hiatus can be responsible of anxiety for the patient and meet the definition of pain induced by treatment. Among the non-pharmacological methods that can be offered to the patient in this context, hypnosis and distraction allow psycho-corporal support acting on certain factors influencing the painful experience of the gesture: duration of the gesture, calm and pleasant environment, etc... That is the context in which the use of virtual reality is of interest. Its use in supporting procedures generating induced pain has already been evaluated in several studies, in particular in the fields of surgery and anaesthesiology. The use of a virtual reality device also seems suitable in the context of epidural injections, but this theoretical and plausible interest remains to be demonstrated. To our knowledge, the literature on the use of a virtual reality headset to support invasive procedures in rheumatology remains poorly developed. The objective of this study is therefore to assess the interest of using a virtual reality headset in the support of pain relief and the management of peri-procedural anxiety when performing epidural injections through the sacrococcygeal hiatus.

02

Conditions studied

  • Radiculopathy

Browse trials for

Keywords

  • epidural injection
  • virtual reality
  • pain management
  • performance anxiety
03

In context

Radiculopathy

483 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

This study's planned enrollment of 70 is above the median of 60 across 373 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

Centre Hospitalier le Mans is the lead sponsor of 44 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient (age ≥ 18 years)
  • Hospitalized in a day-hospitalization department at the General Hospital of Le Mans
  • For whom a diagnosis of radiculalgia with a duration of less than 6 months is made, for which the imaging is compatible with the symptoms according to the clinician's interpretation
  • For whom the indication of at least 2 epidural injections by the way of the sacrococcygeal hiatus is retained
  • Having never experienced an epidural injection through the sacrococcygeal hiatus
  • Patient able and willing to answer the auto-administered surveys
  • Person affiliated or beneficiary of a social security
  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research) after oral and written information

Exclusion criteria

Exclusion Criteria:

  • Patient with comorbidity of epilepsy
  • Patient with a to performing epidural injections through the sacrococcygeal hiatus
  • Patient suffering from blindness and / or deafness
  • Person with a known significant intolerance towards the use of screens and / or virtual reality devices
  • Patient receiving benzodiazepines and / or other sedative treatment
  • Patient with a known depressive disease followed by a psychiatrist
  • Pregnant, breastfeeding or parturient woman
  • Person deprived of liberty by judicial or administrative decision
  • Person under forced psychiatric care
  • Person subject to legal protection
  • Person unable to express consent
  • Patient who had participated in an interventional study during the last 30 days
  • Severely impaired physical and / or mental health which, according to the investigator, may affect the compliance of the study participant
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Using the virtual reality headset for the first injection

    Performing the first ultrasound-guided epidural injection through the sacrococcygeal hiatus using the virtual reality headset, then the second injection following the usual conditions of care without the device

    Device: Virtual reality headset for first injection

  • Experimental
    Using the virtual reality headset for the second injection

    Performing the first ultrasound-guided epidural injection through the sacrococcygeal hiatus following the usual conditions of care, then the second injection using the virtual reality headset

    Device: Virtual reality headset for second injection

Interventions

  • DeviceVirtual reality headset for first injection

    Performing the first ultrasound-guided epidural injection through the sacrococcygeal hiatus using the virtual reality headset

  • DeviceVirtual reality headset for second injection

    Performing the second ultrasound-guided epidural injection through the sacrococcygeal hiatus using the virtual reality headset

06

What researchers measure

Primary outcomes

  1. Evaluation of peri-procedural anxiety when performing epidural injections through the sacrococcygeal hiatus

    Peri-procedural anxiety was measured with State and Trait Anxiety Index (STAI)

    Time frame: Day 7

Secondary outcomes

  1. Assessment of the patient's anxiety

    Assessment of the patient's peri-procedural anxiety using the French version of the APAIS

    Time frame: Immediately after intervention

  2. Measure of the duration of the intervention

    Time frame: Immediately after intervention

  3. Assessment of patient's pain

    Evaluation of maximum periprocedural pain on a numerical scale from 0 to 10

    Time frame: During intervention

  4. Evaluation of the patient satisfaction

    Evaluation of the patient satisfaction with the virtual reality device on a 4-level scale, with values of 1, 2, 3 and 4 (quantitative variable).

    Time frame: Immediately after intervention

  5. Evaluation of the practitioner satisfaction

    Evaluation of the practitioner satisfaction with the virtual reality device on a 4-level scale, with values of 1, 2, 3 and 4 (quantitative variable)

    Time frame: Immediately after intervention

  6. Evaluation of lumbar and radicular pain

    Assessment of lumbar pain on a numerical scale from 0 to 10 and of radicular pain on a numerical scale from numerical scale from 0 to 10

    Time frame: Before intervention

  7. Tolerance and Comfort Questionnaire

    Time frame: Immediately after intervention

  8. Record of undesirable events

    Time frame: Before intervention

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05289999
Lead sponsor
Centre Hospitalier le Mans
Responsible party
Sponsor
First posted
Mar 22, 2022
Start date
Jun 10, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 1, 2026

Study contacts

Christelle JADEAU
Contact
cjadeau@ch-lemans.fr
+33244710781

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion